The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - January 2024
JD Supra: Mergers
JANUARY 18, 2024
Illumina Agrees to Unwind Acquisition of Grail Following Fifth Circuit Decision. On December 15, 2023, the Fifth Circuit vacated the FTC’s order that Illumina unwind its acquisition of Grail—a developer of a multi-cancer early detection (MCED) test.
Let's personalize your content